Actavis At 5: Where Pay-For-Delay Litigation Stands
It's been a little over five years since the U.S. Supreme Court issued its landmark Actavis decision that found payments made by brand-name drugmakers to generics makers in patent settlements can...To view the full article, register now.
Already a subscriber? Click here to view full article